How Much HGH Do Bodybuilders Take?

Bodybuilders typically use human growth hormone at doses many times higher than what a doctor would prescribe for a genuine deficiency. Clinical replacement therapy sits in the range of roughly 1 to 2 IU per day, while the doses reported in bodybuilding communities and documented in sports-medicine literature generally start around 4 IU per day and climb to 10 IU or more among competitive athletes. Even a systematic review of research on young, fit subjects found average doses of about 2.5 mg per day (approximately 7.5 IU), yet noted those were still lower than what athletes typically use in practice. The gap between medical use and bodybuilding use is enormous, and so is the gap between what researchers have studied and what actually circulates in gym culture.

Clinical Replacement Doses as a Baseline

Understanding what counts as a therapeutic dose puts bodybuilding numbers into perspective. Adults with genuine growth hormone deficiency receive doses calibrated to replace what their pituitary gland no longer produces. One long-term study used a mean dose of about 1.6 IU per day over 30 months.¹ Another trial in GH-deficient adults dosed at 0.25 to 0.5 units per kilogram of body weight per week, given as a daily injection at bedtime.² For a man weighing around 80 kilograms, that works out to roughly 3 to 6 IU per week, or less than 1 IU per day. Older adults in one study were started at just 0.5 IU per day and titrated up to 1.5 IU per day over two months.³

These numbers are worth holding in your head because they represent the amount of GH your body is designed to handle. They restore deficient patients to normal levels without routinely producing serious side effects. Everything bodybuilders do with GH is calibrated against this baseline, and the multiplier is striking.

What Bodybuilders Actually Report Using

Pinning down exact bodybuilding doses is harder than it sounds, because nobody runs a randomized trial where they give healthy young men the same amounts competitive bodybuilders inject. Ethical review boards would never approve it. What we do have is a substantial body of sports-medicine literature documenting the patterns from survey data, forensic analyses, and clinical case reports.

A well-known systematic review examined 27 controlled trials involving 303 young, lean, physically fit participants receiving GH at an average of 2.5 mg per day. The review’s authors described this as a five- to tenfold excess over the body’s normal daily GH production rate, yet they still noted it was a lower dose and shorter duration than what athletes typically abuse.⁴ That 2.5 mg translates to roughly 7.5 IU per day, which means the research trials were already giving subjects several times the clinical replacement dose and real-world bodybuilding use exceeds even that.

Self-reported doses from online bodybuilding forums and harm-reduction surveys generally cluster between 4 and 10 IU per day for recreational and intermediate users, with elite or professional-level competitors sometimes reporting 12 to 20 IU or more. Cycles last anywhere from several months to year-round use, often broken into phases where the dose ramps up during the “growth” phase and tapers down during competition prep. Because this information comes from self-reports rather than clinical measurements, the true variability is even wider than those numbers suggest.

How GH Promotes Muscle Growth

Growth hormone does not simply inflate muscle fibers the way anabolic steroids do. Its main route for promoting growth is through stimulating the liver and other tissues to produce insulin-like growth factor 1, commonly called IGF-1.⁵ IGF-1 then acts on muscle and other tissues to stimulate protein synthesis and cell growth. The relationship between systemic IGF-1 (produced by the liver and circulated through the bloodstream) and local IGF-1 (produced inside the muscle tissue itself) adds a layer of complexity that researchers are still working out.

There is also evidence that GH has direct effects on muscle that do not depend on IGF-1 at all. Research has shown that GH promotes the fusion of muscle cells, a step that is essential for muscle fibers to grow larger. This effect appears to work through a different signaling pathway than IGF-1, and the two pathways seem to be additive, meaning GH and IGF-1 together do more than either alone.⁶ This dual mechanism is part of why bodybuilders see GH as a complement to steroids rather than a replacement for them.

What is interesting, though, is that the research trials giving supraphysiological GH doses to healthy subjects mostly show changes in body composition, namely more lean mass and less fat, without clear improvements in actual strength or exercise capacity.⁴ That gap between looking bigger and actually being stronger is one reason the scientific community remains somewhat skeptical about GH’s performance-enhancing value on its own. Bodybuilders, of course, rarely use it on its own.

Why GH Is Almost Always Stacked with Other Drugs

In competitive bodybuilding, GH is almost never used as a solo drug. It is layered on top of anabolic steroids, insulin, and sometimes thyroid hormone in carefully orchestrated protocols. The logic behind this is partly pharmacological and partly based on decades of locker-room experimentation.

The synergy between GH and testosterone has a legitimate biological basis. Research on protein metabolism has found that GH and testosterone are genuinely synergistic when it comes to building lean tissue. The positive effects of testosterone on protein anabolism appear to require a baseline level of GH to be fully realized.⁷ This finding aligns with what bodybuilders have long claimed from experience: GH alone does not produce dramatic muscle gains, but combined with testosterone and other anabolic steroids, the results are greater than either drug would achieve independently.

Insulin enters the picture because GH tends to raise blood sugar by making cells more resistant to insulin’s effects. At bodybuilding doses, this insulin resistance can become quite pronounced. Many bodybuilders inject fast-acting insulin around meals and training to counteract this and to exploit insulin’s own powerful anabolic effects on muscle cells. The combination of GH, insulin, and steroids has become the backbone of professional-level bodybuilding protocols, though it adds significant medical risk.

GH replacement also shifts thyroid hormone balance in the body. Research has shown that GH provokes a drop in free T4 and a rise in free T3, effectively pushing more active thyroid hormone into circulation.⁸ Some bodybuilders add exogenous thyroid hormone (typically T3) to their stack specifically to manage this interaction and keep their metabolic rate elevated during cutting phases.

Side Effects at Supraphysiological Doses

The side-effect profile of GH at bodybuilding doses looks very different from what patients experience at replacement levels. In the systematic review of trials using about 2.5 mg per day in healthy subjects, the typical excess-GH side effects showed up in roughly 15 to 44 percent of participants. These included fluid retention, joint pain, carpal tunnel syndrome, and excessive sweating.⁴ Since bodybuilders use as much or more than those trial doses, these side effects are common complaints in the community.

Carpal tunnel syndrome deserves special mention because it is one of the most recognizable signs of GH excess. In people with acromegaly, a condition where the body overproduces GH, the median nerve in the wrist becomes measurably swollen. Research on acromegalic patients found the cross-sectional area of the median nerve was roughly 75 percent larger than in healthy controls, and it only partially shrank after treatment brought GH levels back down.⁹ Bodybuilders using high-dose GH are essentially giving themselves a mild, self-induced form of acromegaly, so wrist numbness and tingling are among the first warning signs many notice.

Longer-term concerns include the possibility of accelerating tumor growth (GH and IGF-1 are growth signals, after all), worsening glucose control to the point of developing type 2 diabetes, and the cardiovascular strain of carrying extra mass while also pushing insulin and GH levels far above normal. The full long-term risk profile at bodybuilding doses has never been properly studied because it cannot be ethically studied in a trial setting.

The Distended Gut Problem

One of the most visible and debated side effects in modern bodybuilding is the severely distended abdomen seen in some elite competitors, sometimes called “Palumboism” after bodybuilder Dave Palumbo. This condition, more formally called abdominal hypertrophy syndrome, is associated with prolonged use of high-dose GH and insulin alongside anabolic steroids.¹⁰

The exact mechanism is not fully understood. Several explanations have been proposed, including growth of the internal organs (the liver, intestines, and kidneys all have GH receptors), increased fat deposits around the organs rather than under the skin, and changes in connective tissue and collagen. What makes it especially insidious is that bodybuilders are simultaneously extremely lean in their subcutaneous fat while their abdomens protrude as if distended from the inside. The condition has become one of the most recognized aesthetic downsides of the modern mass-monster era, and many fans and competitors cite it as evidence that drug protocols have gone too far.

Counterfeit and Underdosed Products

Because pharmaceutical-grade GH requires a prescription and is expensive, a large proportion of the supply used by bodybuilders comes from underground labs, gray-market imports, and internet pharmacies. The quality of these products is wildly inconsistent. A study that tested GH products purchased from online sources found that every single sample contained significantly less somatropin than the label claimed.¹¹

The problem extends beyond just underdosing. A forensic analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders found that about a third were substandard (wrong dosage), another third were outright counterfeit (the actual ingredients did not match the label at all), and only about one in five turned out to be the genuine product.¹² This means a bodybuilder who thinks they are injecting 10 IU of GH per day might be getting considerably less, getting a different substance entirely, or getting nothing active at all. It also means that dose reports from the community are inherently unreliable, because users are reporting what the label says, not what they are actually injecting.

This reality complicates every conversation about “how much bodybuilders take.” If two-thirds of black-market products are either underdosed or fake, the stated dose and the actual dose may have little relationship to each other. A user experiencing strong side effects at a supposedly moderate dose might actually be taking a full dose from a rare legitimate product, while someone claiming to tolerate very high doses might be injecting mostly filler.

How Anti-Doping Agencies Try to Detect GH

Detecting GH misuse is one of the hardest challenges in sports drug testing. The core problem is that injected recombinant GH is chemically identical or nearly identical to the hormone the body produces naturally, and natural GH levels fluctuate wildly throughout the day in response to sleep, exercise, and stress. Two testing approaches have been approved by the World Anti-Doping Agency.¹³

The first approach, the isoform test, exploits the fact that your pituitary gland produces GH in several slightly different molecular forms, while pharmaceutical GH is exclusively the 22-kilodalton form. After an injection, the ratio of that single form to total GH shifts. The main drawback is that this window of detection is very short, roughly 12 to 24 hours after the last injection.¹⁴ An athlete who stops injecting two days before a test can easily pass.

The second approach, the biomarker test, measures IGF-1 and a collagen marker called P-III-NP, both of which rise in a dose-dependent way when someone uses GH. This test has a longer detection window of one to two weeks but is less specific, since these markers vary with age, sex, fitness level, and other factors.¹⁴ Newer methods are also being developed to catch GH analogs. A recent study demonstrated that somatrogon, a long-acting GH analog, can be detected in urine for at least 96 hours after injection.¹⁵

For bodybuilders, anti-doping detection is mostly irrelevant because most bodybuilding federations either do not test or test only in “natural” divisions. But the narrow detection windows help explain why GH became so popular in competitive sports more broadly: athletes realized early on that it was nearly undetectable.

How GH Use Got Started in Bodybuilding

Growth hormone was first isolated from human pituitary glands in the 1950s. Athletes recognized its anabolic potential and had begun using it by the early 1980s, at least a decade before adult endocrinologists started prescribing it therapeutically for GH-deficient adults.¹⁶ Early supplies came from cadaver-derived pituitary extracts, which were scarce and carried the risk of prion disease. The introduction of recombinant DNA technology in 1985 made synthetic GH available in unlimited quantities, and use in bodybuilding expanded rapidly through the late 1980s and 1990s.

The timing lines up with visible changes in competitive bodybuilding aesthetics. Competitors in the 1970s and early 1980s, the era before widespread GH and insulin use, were large but retained relatively tapered waistlines. By the mid-1990s, competitors were noticeably bigger overall but also thicker through the midsection. Whether GH is the primary driver of that aesthetic shift or simply one piece of a broader polypharmacy escalation is debated, but the correlation is hard to ignore.

Sex Differences in GH Response and Dosing

Men and women do not respond identically to GH, and this creates a particular challenge for female athletes or bodybuilders considering its use. Women naturally produce GH in a different secretory pattern than men, with more frequent and higher pulses. Research into female use of GH-releasing peptides has found that women report concerns about how these sex-based differences in GH pulse patterns complicate figuring out appropriate doses and cycling schedules.¹⁷

Women also tend to produce more GH naturally but have lower IGF-1 levels than men at baseline, partly because estrogen blunts the liver’s IGF-1 response to GH. This means a given dose of exogenous GH may produce a different IGF-1 response in women than in men, and the effective dose for a desired body-composition change is not simply a scaled-down version of male protocols. In clinical settings, women with GH deficiency typically require higher doses per kilogram to achieve the same IGF-1 normalization as men. Whether this translates directly to bodybuilding dosing is unclear, but it underscores that borrowing a male athlete’s protocol is not a straightforward proposition for female users.